FDA Approves First Cellular Therapy to Treat Patients with Unresectable or Metastatic Melanoma
For Immediate Release: February 16, 2024 Today, the U.S. Food and Drug Administration approved Amtagvi, the first cellular therapy indicated for the treatment of adult patients with a type of skin cancer (melanoma) that is unable to be removed with surgery …